A Better Tool to Diagnose Tuberculosis

Key points
- Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods.
- The Journal of Visualized Experiments (JoVE) is the first and only Pubmed and Medline indexed academic journal devoted to publishing research in the biological sciences in video format.
- Currently, TB is diagnosed through either a skin test, which produces a small bump on the patient's arm when administered and needs to be checked after 72 hours, and through smear microscopy, a method that was developed over a century ago.
- "The expert MTB/RIF assay is intended for use with specimens from patients for whom there is suspicion of pulmonary tuberculosis and who fulfill the criteria outlined in the accompanied text," said Dr.
Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE).
Currently, TB is diagnosed through either a skin test, which produces a small bump on the patient's arm when administered and needs to be checked after 72 hours, and through smear microscopy, a method that was developed over a century ago. The new test is fully automated and takes about an hour and a half to give results. It is also able to determine if the patient is infected with a multidrug-resistant strain of the bacteria.
"The expert MTB/RIF assay is intended for use with specimens from patients for whom there is suspicion of pulmonary tuberculosis and who fulfill the criteria outlined in the accompanied text," said Dr. Bodmer, who co-authored the article.
WHO endorsed the test in 2010, and is working to roll it out across tuberculosis-affected countries. An important aspect of this is training people to use the device, and the JoVE video-article will help with standardization. JoVE is the only peer reviewed, PubMed-indexed science journal to publish all of its content in both text and video format.
"TB is one of the most deadly infectious diseases worldwide and accurate and rapid diagnosis is essential for timely and proper treatment. This test is expected to dramatically improve the diagnosis of TB," said JoVE Science Editor, Dr. Charlotte Frank Sage. "Publication of the protocol in JoVE allows researchers around the world to see a detailed demonstration of this diagnostic tool and will aid in establishing this technology in their laboratories and clinics."
About The Journal of Visualized Experiments:
The Journal of Visualized Experiments (JoVE) is the first and only Pubmed and Medline indexed academic journal devoted to publishing research in the biological sciences in video format. Using an international network of videographers, JoVE films and edits videos of researchers performing new experimental techniques at top universities, allowing students and scientists to learn them much more quickly. As of January 2012 JoVE has released 59 monthly issues including over 1500 video-protocols on experimental approaches in developmental biology, neuroscience, microbiology and other fields.
###
Katherine Scott
Science Communications
The Journal of Visualized Experiments
p. 617.945.9051
e. Katherine.Scott@JoVE.com
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsHigh-cost hospitals do not appear to have better survival rates for sepsis patients
Increased hospital spending at high-cost hospitals does not appear to be associated with better short-term survival rates for patients with sepsis, according to a report in the February 28 issue of Archives of Internal…
1 March 2011
NewsStudy shows a serious risk of side effects when having latent tuberculosis therapy over age 65
A new study found that there is a serious increased risk of side effects requiring hospitalization in people over the age of 65 who are going through latent tuberculosis infection therapy, according to a study published…
12 January 2011
NewsBetter HIV screening worthwhile in U.S., study finds
Expanding screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years, researchers projected on Monday.…


